...
首页> 外文期刊>Pharmacognosy Research >Ethanolic extracts of Alstonia Scholaris and Bacopa Monniera possess neuroleptic activity due to anti-dopaminergic effect
【24h】

Ethanolic extracts of Alstonia Scholaris and Bacopa Monniera possess neuroleptic activity due to anti-dopaminergic effect

机译:Alstonia Scholaris和Bacopa Monniera的乙醇提取物具有抗多巴胺能作用,具有抗精神病活性。

获取原文

摘要

Background:An increased inclination has been observed for the use of herbal drugs in chronic and incurable diseases. Treatment of psychiatric diseases like schizophrenia is largely palliative and more importantly, a prominent adverse effect prevails with the majority of anti-psychotic drugs, which are the extrapyramidal motor disorders. Existing anti-psychotic drug therapy is not so promising, and their adverse effect is a matter of concern for continuing the therapy for long duration.Objective:This experimental study was done to evaluate the neuroleptic activity of the ethanolic extracts of two plants Alstonia Scholaris and Bacopa Monnieri with different anti-psychotic animal models with a view that these plant extracts shall have no or at least reduced adverse effect so that it can be used for long duration.Materials and Methods:Two doses of both the extracts (100 and 200 mg/kg) and also standard drug haloperidol (0.2 mg/kg) were administered to their respective groups once daily with 5 different animal models. After that, the concentration of the dopamine neurotransmitter was estimated in two different regions of the brain viz. frontal cortex and striatum.Results:The result of the study indicated a significant reduction of amphetamine-induced stereotype and conditioned avoidance response for both the extracts compared with the control group, but both did not have any significant effect in phencyclidine-induced locomotor activity and social interaction activity. However, both the extracts showed minor signs of catalepsy compared to the control group. The study also revealed that the neuroleptic effect was due to the reduction of the dopamine concentration in the frontal cortex region of the rat brain. The results largely pointed out the fact that both the extract may be having the property to alleviate the positive symptoms of schizophrenia by reducing the dopamine levels of dopaminergic neurons of the brain.Conclusion:The estimation of dopamine in the two major regions of brain indicated the alteration of dopamine levels was the reason for the anti-psychotic activity as demonstrated by the different animal models.
机译:背景:已经发现,在慢性和不治之症中使用草药的意愿有所增加。精神分裂症等精神疾病的治疗在很大程度上是姑息性的,更重要的是,大多数抗精神病药物(锥体外系运动障碍)普遍存在显着的不良反应。现有的抗精神病药物疗法前景不佳,其不良反应仍是长期持续治疗的关注点。目的:本实验研究旨在评估两种植物阿尔斯通氏菌和两种植物的乙醇提取物的抗精神病活性。 Bacopa Monnieri具有不同的抗精神病动物模型,认为这些植物提取物应无副作用或至少减少副作用,因此可以长期使用。材料和方法:两种剂量的两种提取物(100和200 mg / kg)以及标准药物氟哌啶醇(0.2 mg / kg)每天分别与5种不同的动物模型一起给药至各自的组。此后,在大脑的两个不同区域中估计多巴胺神经递质的浓度。结果:研究结果表明,与对照组相比,两种提取物均显着降低了苯丙胺诱导的刻板印象和条件回避反应,但对苯环利定诱导的自发活动和运动均无明显影响。社会互动活动。但是,与对照组相比,两种提取物均显示出轻微的僵直症状。该研究还表明,这种抗精神病药的作用是由于降低了大鼠大脑额叶皮层区域中多巴胺的浓度。结果在很大程度上指出了以下事实:两种提取物均具有通过降低大脑中多巴胺能神经元的多巴胺水平来减轻精神分裂症阳性症状的特性。结论:对大脑两个主要区域中多巴胺的估计表明:如不同的动物模型所示,多巴胺水平的改变是抗精神病活性的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号